SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001453072-17-000013
Filing Date
2017-02-14
Accepted
2017-02-14 14:13:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 alsk12311613gKMPH.US.txt SC 13G 17216
  Complete submission text file 0001453072-17-000013.txt   18796
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Subject) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88808 | Film No.: 17606928
SIC: 2834 Pharmaceutical Preparations

Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

IRS No.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G